Inverness Medical Innovations Inc.
51 Sawyer Rd
Ste 200
Waltham
MA
02453-3448
United States
(781) 647-3900
Product(s):
Manufactures consumer pregnancy and fertility/ovulation tests and rapid point-of-care diagnostics
Ownership:
Public
Exchange:
NYSE
symbol:
IMA
2004 Revenue:
$376,910,000
2005 Revenue:
$421,850,000
2006 Revenue:
$569,454,000
2007 Revenue:
$839,540,000
2008 Revenue:
$1,671,426,000
Yahoo Quotes:
President:
Ron Zwanziger
CEO:
Ron Zwanziger Management:
David Scott, CSO
Jerry McAleer, VP-R&D, cardiology
Hilde Eylenbosch, president-consumer diagnostics
David Toohey, president-professional diagnostics
John Yonkin, president-US point of care, Inverness Medical Nutritionals
Ellen Chiniara, general counsel, asst. secretary
Paul T. Hempel, SVP-leadership development & special counsel
David Teitel, CFO
Inverness Biomedical Innovations Inc.
Permalink
RECENT BLOG POSTS
- Is Valeant About To Make A Bold Bid For Bausch & Lomb?
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
